Corrigendum to: Randomized, Ascending Dose, Phase 2 Study of KHK4083, an Anti-OX40 Monoclonal Antibody, in Moderately Active Ulcerative Colitis

Detalles Bibliográficos
Autores principales: Kierkus, Jaroslaw, Pesegova, Marina, Klopocka, Maria, Brankovic, Marija, Kasai, Noriyuki, Efuni, Sergey, Kong, Jennifer, Nakajima, Yu, Jordan, Christina, Matsui, Takeshi, Feagan, Brian G, Strout, Vincent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802177/
https://www.ncbi.nlm.nih.gov/pubmed/36780244
http://dx.doi.org/10.1093/crocol/otaa092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802177/
https://www.ncbi.nlm.nih.gov/pubmed/36780244
http://dx.doi.org/10.1093/crocol/otaa092

Ejemplares similares